Suchergebnisse - "Hou, Zhiguo"

PubPharm (2)

1

Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer : The APPROVE Randomized Clinical Trial

enthalten in: JAMA oncology | 2022

von Wang, T. | Tang, J. | Yang, H. | +14

2

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer : The REALITY Randomized Clinical Trial

enthalten in: JAMA oncology | 2022

von Lin, Y. | Qin, S. | Li, Z. | +22

CommentIn: JAMA Oncol. 2022 Feb 1;8(2):250-251. - PMID 34913944

1
[1]